Integral Health Asset Management, LLC Alector, Inc. Transaction History

Integral Health Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$21.65 - $39.49 $757,750 - $1.38 Million	-35,000 Closed	0 $0
Q2 2021 Aug 30, 2021	SELL	$15.5 - $22.48 $542,500 - $786,800	-35,000 Reduced 50.0%	35,000 $729,000
Q2 2021 Aug 13, 2021	BUY	$15.5 - $22.48 $232,500 - $337,200	15,000 Added 27.27%	70,000 $1.46 Million
Q1 2021 May 10, 2021	SELL	$14.84 - $22.23 $1.63 Million - $2.45 Million	-110,000 Reduced 66.67%	55,000 $1.11 Million
Q4 2020 Feb 16, 2021	BUY	$9.4 - $16.7 $1.27 Million - $2.25 Million	135,000 Added 450.0%	165,000 $2.5 Million
Q3 2020 Nov 16, 2020	BUY	$10.54 - $24.96 $316,200 - $748,800	30,000 New	30,000 $316,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $153M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.